Benefit reductions for Cardiac Implantable Electronic Devices

Learn about how we are reducing benefits for Cardiac Implantable Electronic Devices (CIEDs).

Timeline

We released a high-level summary of submissions to Consultation Paper 9. This was stage 1 of the consultation.

We are now planning stage 2, which will involve discussions with stakeholder groups.

Past activities

DateActivity
12 July – 6 September 2024Sought stakeholders’ views on how to implement the MSAC advice and reduce benefits for technical support services, via Consultation paper 9 . This was stage 1 of the consultation.
1 July 2024Second scheduled benefit reduction of 20% of the gap (device component only)
19 April 2024Announced next steps for benefit reductions for CIED after MSAC advice. The proportion of the benefit corresponding to the device component was recalculated at 56.3%.
16 April 2024The MSAC provided advice on the reasonable cost of technical support services for CIEDs
1 July 2023

First scheduled benefit reduction of 40% of the gap on 1 July 2023 (device component only). See the updated benefits.

The device component of the CIED benefit was estimated at 54% of the current CIED benefit. We based this estimate on the information provided to the MSAC by the industry applicant.

7 June 2023Published revised reduced CIED benefits (device component only) PHI 36/23 Revised benefit reductions for Cardiac Implantable Electronic Devices.
16 May 2023Published reduced CIED benefits (device component only) effective 1 July 2023 PHI 29/23 Benefit reductions to Cardiac Implantable Electronic Devices.
January to February 2023We worked with the Medical Technology Association of Australia (MTAA) Cardiac Forum on an interim solution: reduce CIED benefits for the device component only, effective 1 July 2023.
Date last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.